Peer Review History
| Original SubmissionSeptember 21, 2020 |
|---|
|
PONE-D-20-29685 Systemic sodium valproate ameliorates impaired short-term memory induced by associative morphine tolerance in rats PLOS ONE Dear Dr. Fathollahi, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. In addition to the the reviewer's comment (attached), I am also of the opinion that the manuscript needs major editing of the language and also demonstrate changes in GABAA α2 protein in the hippocampal slices by immunohistochemical analysis, since in changes in mRNA levels does not translate in the expression the respective protein as mRNA undergoes transcriptional modifications. all the changes you require for acceptance versus which changes you recommend. The manuscript needs to revised according to the comments of the editor and the reviewer before reconsideration of the manuscript. Please submit your revised manuscript by Jan 21 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols We look forward to receiving your revised manuscript. Kind regards, Prasun K Datta, Ph.D Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Thank you for including your ethics statement: "Tarbiat Modares University". a. Please amend your current ethics statement to confirm that your named ethics committee specifically approved this study. b. Once you have amended this/these statement(s) in the Methods section of the manuscript, please add the same text to the “Ethics Statement” field of the submission form (via “Edit Submission”). For additional information about PLOS ONE submissions requirements for ethics oversight of animal work, please refer to http://journals.plos.org/plosone/s/submission-guidelines#loc-animal-research 3. In your Data Availability statement, you have not specified where the minimal data set underlying the results described in your manuscript can be found. PLOS defines a study's minimal data set as the underlying data used to reach the conclusions drawn in the manuscript and any additional data required to replicate the reported study findings in their entirety. All PLOS journals require that the minimal data set be made fully available. For more information about our data policy, please see http://journals.plos.org/plosone/s/data-availability. Upon re-submitting your revised manuscript, please upload your study’s minimal underlying data set as either Supporting Information files or to a stable, public repository and include the relevant URLs, DOIs, or accession numbers within your revised cover letter. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories. Any potentially identifying patient information must be fully anonymized. Important: If there are ethical or legal restrictions to sharing your data publicly, please explain these restrictions in detail. Please see our guidelines for more information on what we consider unacceptable restrictions to publicly sharing data: http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. Note that it is not acceptable for the authors to be the sole named individuals responsible for ensuring data access. We will update your Data Availability statement to reflect the information you provide in your cover letter. 4. Please include your tables as part of your main manuscript and remove the individual files. Please note that supplementary tables should remain as separate "supporting information" files. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Partly ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: No ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: Reviewer Recommendation and Comments Manuscript PONE-D-20-29685 The present study tested the effects of the anticonvulsant, mood-stabilizing, and GABA facilitator sodium valproate on the behavioral tolerance induced by morphine. The authors first investigated the development of unconditioned (non-associative response) and learned tolerance (context-dependent response) to the analgesic effects of morphine using the tail-flick test. Then they examined morphine tolerance on hippocampal-dependent tasks named spatial-working and short-term memory procedures using the Y-maze apparatus. Finally, the authors examined the changes in the expression of hippocampal GABAA receptors underlying morphine tolerance using the quantitative real-time PCR technique to detect GABAA �2 mRNA. Overall, the authors report that both learned and non-associative morphine tolerance influence short-term memory and the subjacent expression of GABAA �2 mRNA. Overall, the results are interesting and add to our understanding of the behavioral and molecular aspects of the learned tolerance to morphine effects. Morphine is used as a painkiller to treat moderate, severe, and chronic pain. Considering that those suffering from chronic pain have the potential to misuse their medication and taking into account that morphine has the potential to be highly addictive, as tolerance to it develops rapidly, any additional information that can be applied to the potential abuse liability is extremely relevant and timely. However, before the manuscript can be considered for publication, the authors should address several points. Specific concerns are provided below: - In General, the manuscript is understandable but it will benefit from a grammar correction. - Page numbers are missing. - First page of the Introduction, line 7: MOR (what does it mean?) - Methods section (Drugs administration): The authors must inform the basis for the choice of drug dose and drug dosages. - If I understand, regarding the learned tolerance (section 2.3.1.2), it seems that the tail-flick analysis was performed out of the morphine-related context. The authors are invited to explain in more detail how learned morphine tolerance can be evoked when the test of analgesia is performed in the absence of contextual cues previously associated with drug effects. - Statistical analysis is correctly informed but, in the Results section, the data related to the statistical inferences resulting from ANOVA are missing (degrees of freedom, F values, probability). - There are some problems related to the number of figures and figures described in the manuscript. For instance, in section 3.1, the last paragraph, the authors inform: … (Fig 1 B-C). However, C is not a part of figure 1. Indeed, graphic C is a part of the supplementary material. Moreover, besides the poor quality, the figures are difficult to understand and the small fonts used do not help the reader. However, the biggest problem is the excessive use of asterisks (mainly in figures 3 and 4) that turns the figures absolutely incomprehensible to me. - Section 3.4: the authors defined what they call “decision-making criteria”, or “decision index”. Have other studies used this same approach to name the first latency to enter an arm of a maze? - The discussion of the data is difficult to follow without a good analysis of the figures provided. Therefore, before the manuscript can be considered for publication, the authors should address the concerns provided above. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
PONE-D-20-29685R1 Unconditioned and learned morphine tolerance influence hippocampal-dependent short-term memory and the subjacent expression of GABA-A receptor alpha subunits PLOS ONE Dear Dr. Fathollahi, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please revise the manuscript as per comments of the reviewer. Please submit your revised manuscript by Jul 10 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Prasun K Datta, Ph.D Academic Editor PLOS ONE Journal Requirements: Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: (No Response) ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: Manuscript PONE-D-20-29685R1 General appointments This is a re-review of the study of Fathollahi et al., now entitled “Unconditioned and learned morphine tolerance influence hippocampal-dependent short-term memory and the subjacent expression of GABA-A receptors alpha subunits”. Based on the previous reviewer’s criticisms the authors performed profound (and huge) changes to the article. These changes help to turn the manuscript more understandable. The study brings new and important information on the behavioral and neural events underlying morphine tolerance. However, after this second round of review, I think that the manuscript still needs to be improved to be considered for publication in PONE. In general, the manuscript lacks organization. My points to be considered by the authors are provided below: 1. The title is now precise. 2. My first criticism concerns the excessive number of abbreviations used in the manuscript. In my point of view, it is very annoying having to come back every time in the reading to remember each of the abbreviations used. This does not testify against the quality of the study but severely limited the enthusiasm of the reader. I think the authors must use only the most important acronyms, including NANT, AMT, STM, and SWM. I recommend that the authors use GABAr-�1 (or �2, and �5) instead of Gabr or Gabrs, since the word GABA itself is an acronym. 4. Another concern about the study is the absolute absence of a topic informing the total number of animals used (including losses, if any), and the number of animals by group subdivisions. In other words, how many groups were used and how many rats belonging to each group. This is important to the reader considering that any inference on the statistical analysis requires such information and this could be done through the presentation of a schematic picture of the procedures used in the study. In fact, considering the number of different dependent variables collected, this is necessary for each one of the experimental procedures used, including the STM and SWM. 5. On page 7, line 16. How long habituation to the new context lasts before saline injections? 6. Page 9, line 14. After the word “method”, insert the corresponding reference. 7. Page 18, last line, after Griesel et al., the year of publication is missing. 8. Page 19, line 23 (We observed no significant...). Looking at figure 3, It seems to me that the author’s assumption does not correlate with the information posted in the figure. If I understand the point, considering that the overall locomotion is correlated with the percentage of arm entries, both NAMT and AMT groups have reduced (and not increased) novel arm entries. Therefore, morphine decreases novel arm exploration of NAMT and AMT groups, which is reversed by valproate. Perhaps may this be due to my inability to understand the author's inference but the manuscript can largely benefit from a more organized way of discussing the data. I suggest dividing both the results and the discussion section into behavioral (morphine tolerance, short-term memory, spatial-working memory) and molecular topics. 9. Page 20, line 8 (In accordance with...). I was not able to find such data in the present report. 10. Page 21, line 14. Pervious (previous?) documents were reviewed... Reference is missing. Idem line 19 (It was noted that impairment...). 11. On page 20, line 22, the authors stated that “One of the possible mechanisms assumed to be involved in impaired memory retrieval in the Y-maze may be a manifest attenuation in synaptic performance during morphine exposure and AMT development”. Indeed, chronic exposure to morphine or heroin leads to the impairment of hippocampal LTP and induces deficits in cognitive and memory-task performance, as shown in the present study. However, the authors right after arguing that “Since morphine may abuse learning and memory circuits, a specific synaptic potentiation, which is the same as LTP, is formed in the brain”. The authors are invited to add a paragraph on this subject to discuss the learning and memory disruption in AMT rats — and the improvement following VPA, as well —, in terms of extinction impairment. 12. Graphics are now visually more understandable but progress can be made by applying a title above each figure to avoid the reader going back and forth to the manuscript. Again, I gently ask the authors to increase the size of the fonts since, in case of acceptance of the manuscript, the figures will be reduced in size. Regarding this point, In Figures 1C, 3B, and 3C, the differences between the novel and the other arm, with the start arm, could add a way to easily understand the data. It can just be done by inserting a data inset into the figures. 13. Pay attention to several typo errors and others along with the manuscript. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 2 |
|
Unconditioned and learned morphine tolerance influence hippocampal-dependent short-term memory and the subjacent expression of GABA-A receptor alpha subunits PONE-D-20-29685R2 Dear Dr. Fathollahi, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Prasun K Datta, Ph.D Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: |
| Formally Accepted |
|
PONE-D-20-29685R2 Unconditioned and learned morphine tolerance influence hippocampal-dependent short-term memory and the subjacent expression of GABA-A receptor alpha subunits Dear Dr. Fathollahi: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Prasun K Datta Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .